D. S. Stephens, B. Greenwood, and P. Brandtzaeg, Epidemic meningitis, meningococcaemia, and Neisseria meningitidis, Lancet, vol.369, pp.2196-2210, 2007.
DOI : 10.1016/s0140-6736(07)61016-2

S. P. Yazdankhah, P. Kriz, G. Tzanakaki, J. Kremastinou, and J. Kalmusova, Distribution of Serogroups and Genotypes among Disease-Associated and Carried Isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway, J Clin Microbiol, vol.42, pp.5146-5153, 2004.

M. L. Zarantonelli, M. Lancellotti, A. E. Deghmane, D. Giorgini, and E. Hong, Hyperinvasive genotypes of Neisseria meningitidis in France, Clin Microbiol Infect, vol.14, pp.467-472, 2008.

C. Brehony, K. A. Jolley, and M. C. Maiden, Multilocus sequence typing for global surveillance of meningococcal disease, FEMS Microbiol Rev, vol.31, pp.15-26, 2007.
DOI : 10.1111/j.1574-6976.2006.00056.x

URL : https://academic.oup.com/femsre/article-pdf/31/1/15/18127550/31-1-15.pdf

M. C. Schneider, R. M. Exley, S. Ram, R. B. Sim, and C. M. Tang, Interactions between Neisseria meningitidis and the complement system, Trends Microbiol, vol.15, pp.233-240, 2007.
DOI : 10.1016/j.tim.2007.03.005

L. H. Harrison, C. L. Trotter, and M. E. Ramsay, Global epidemiology of meningococcal disease, Vaccine, vol.27, pp.51-63, 2009.
DOI : 10.1016/j.vaccine.2009.04.063

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, and H. Claus, Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

H. S. Marshall, P. C. Richmond, M. D. Nissen, A. Wouters, and J. Baber, A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults, Vaccine, vol.31, pp.1569-1575, 2013.

E. Hong, M. M. Giuliani, A. E. Deghmane, M. Comanducci, and B. Brunelli, Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa, Vaccine, vol.31, pp.1113-1116, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02092889

F. Caron, I. P. Du-chatelet, J. P. Leroy, C. Ruckly, and M. Blanchard, From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect Dis, vol.11, pp.455-463, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02083160

V. Delbos, L. Lemee, J. Benichou, G. Berthelot, and M. K. Taha, Meningococcal carriage during a clonal meningococcal B outbreak in France, Eur J Clin Microbiol Infect Dis, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02074433

D. S. Kellogg, W. L. Peacock, . Jr, W. E. Deacon, L. Brown et al., Neisseria gonorrhoeae. I. Virulence Genetically Linked to Clonal Variation, J Bacteriol, vol.85, pp.1274-1279, 1963.

M. C. Maiden, J. A. Bygraves, E. Feil, G. Morelli, and J. E. Russell, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc Natl Acad Sci U S A, vol.95, pp.3140-3145, 1998.

M. K. Taha, D. Giorgini, M. Ducos-galand, and J. M. Alonso, Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000, J Clin Microbiol, vol.42, pp.4158-4163, 2004.

J. A. Vazquez, L. Arreaza, C. Block, I. Ehrhard, and S. J. Gray, Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections, Antimicrob Agents Chemother, vol.47, pp.3430-3434, 2003.

E. Hong, D. Giorgini, A. E. Deghmane, and M. K. Taha, Functional impacts of the diversity of the meningococcal factor H binding protein, Vaccine, vol.31, pp.183-189, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02085530

K. A. Jolley, M. S. Chan, and M. C. Maiden, mlstdbNet -distributed multi-locus sequence typing (MLST) databases, BMC Bioinformatics, vol.5, p.86, 2004.

E. Murphy, L. Andrew, K. L. Lee, D. A. Dilts, and L. Nunez, Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis, J Infect Dis, vol.200, pp.379-389, 2009.

K. L. Seib, B. Brunelli, B. Brogioni, E. Palumbo, and S. Bambini, Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies, Infect Immun, vol.79, pp.970-981, 2011.

M. C. Maiden, A. B. Ibarz-pavon, R. Urwin, S. J. Gray, and N. J. Andrews, Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, vol.197, pp.737-743, 2008.

H. Claus, M. C. Maiden, D. J. Wilson, N. D. Mccarthy, and K. A. Jolley, Genetic analysis of meningococci carried by children and young adults, J Infect Dis, vol.191, pp.1263-1271, 2005.

J. W. Marsh, K. A. Shutt, R. Pajon, M. M. Tulenko, and S. Liu, Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates, Vaccine, vol.29, pp.6049-6058, 2011.

M. K. Taha, Immunisation against meningococcus B, Lancet, vol.382, p.936, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093786

E. Loh, E. Kugelberg, A. Tracy, Q. Zhang, and B. Gollan, Temperature triggers immune evasion by Neisseria meningitidis, Nature, vol.502, pp.237-240, 2013.

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, and H. Claus, Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, pp.416-425, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

M. E. Ramsay, N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller, Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis, Bmj, vol.326, pp.365-366, 2003.